Works matching IS 16620631 AND DT 2019 AND VI 13 AND IP 1

Results: 34
    1

    Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

    Published in:
    Case Reports in Gastroenterology, 2019, v. 13, n. 1, p. 37, doi. 10.1159/000496453
    By:
    • Suzuki, Taketo;
    • Mizoshita, Tsutomu;
    • Sugiyama, Tomoya;
    • Hirata, Yoshikazu;
    • Kimura, Yoshihide;
    • Suzuki, Yuka;
    • Yamada, Tomonori;
    • Tsukamoto, Hironobu;
    • Mizushima, Takashi;
    • Sugimura, Naomi;
    • Katano, Takahito;
    • Tanida, Satoshi;
    • Kataoka, Hiromi;
    • Sasaki, Makoto
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34